Physician profile
Amy Le
NPI 1740980200
$1,213.10
in general payments reported to CMS, 2019-2025
15 companies · $174 in 2025
The $174 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $353 · 2024: $685 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,213.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $202.85 | 2023-2024 | |
| Hologic Sales and Service, LLC | $134.72 | 2024 | Aptima |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.99 | 2024 | |
| Lilly USA, LLC | $124.34 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Glaxosmithkline, LLC. | $100.13 | 2023-2025 | Bexsero, Pediarix, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $94.28 | 2023-2024 | |
| Genzyme Corporation | $89.80 | 2023 | |
| Merck Sharp & Dohme LLC | $89.26 | 2023-2025 | Gardasil 9, Vaxelis, Capvaxive |
| Sanofi-Aventis U.S. LLC | $61.32 | 2025 | |
| Exact Sciences Corporation | $59.41 | 2023-2024 | Cologuard Collection Kit |
| Indivior INC. | $38.50 | 2024 | Sublocade |
| Viiv Healthcare Company | $29.43 | 2024 | Apretude |
| Amgen INC. | $22.47 | 2025 | Evenity |
| Pfizer INC. | $21.71 | 2023 | |
| Paratek Pharmaceuticals, INC. | $19.89 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.